Home
 /
Papers
 /
Biochemistry
 /
“Design principles of a membrane-spanning ubiquitin ligase”
Preprint
Open access
V1
Top 1% · Validated by QED

“Design principles of a membrane-spanning ubiquitin ligase”

Carys Williams, Laura M. Nocka, George Hedger +16 more
September 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2025.09.11.675358
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Biochemistry this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

The first structure of a membrane-spanning E3 ubiquitin ligase reveals a 'fishing pole' mechanism—a solitary helix suspending an activated RING domain—establishing the design principles governing how extracellular signals directly control cytoplasmic ubiquitylation.

QED claims analysis

Summary

The MEGF8-MOSMO-MGRN1 complex employs a fishing pole architecture where a flexible solitary α-helix suspends a stabilized and precisely oriented RING domain beneath a membrane-embedded platform to ubiquitylate cell surface receptors, representing a distinct structural paradigm among membrane-spanning E3 ligases that is optimized for recognizing folded receptor substrates rather than translocating unfolded polypeptides.

See full analysis
Main Claim 1 –

MOSMO platform and MEGF8 helix suspend MGRN1 RING

Supporting evidence

  • MEGF8–MOSMO conserved interface buries 953 Å2 with lipid contacts
  • MEGF8–MOSMO interaction is required for SMO ubiquitylation activity
  • MGRN1 allosterically modulates MEGF8–MOSMO interface dynamics
Main Claim 2 –

MGRN1 binds MEGF8 ICD via pre-engager, engager, RING

Supporting evidence

  • MEGF8 ICD–MGRN1 forms exceptionally stable, HDX-protected complex
  • MEGF8 binding activates MGRN1 RING, boosting catalysis tenfold
  • Carpenter syndrome MEGF8 mutations impair MMM, elevating Hedgehog signaling
Main Claim 3 –

MEGF8 SAH flexible tether requires precise positioning for ubiquitylation

Supporting evidence

  • MMM architecture is distinct from channel-forming membrane E3 ligases

Abstract

Receptor-type E3 ubiquitin ligases are membrane-spanning assemblies that enable extracellular signals to directly control ubiquitylation in the cytoplasm. Despite playing widespread roles in tissue patterning and homeostasis, metabolism, and immunity, their structures and mechanisms remain poorly understood. Using cryo-electron microscopy, integrated with biophysical and functional studies, we visualized an E3 complex composed of two transmembrane proteins, MEGF8 and MOSMO, and the intracellular RING-family protein MGRN1. This MEGF8-MOSMO-MGRN1 (MMM) complex regulates left-right patterning of the body axis and the development of multiple organs, partly by attenuating signaling through the Hedgehog pathway. We find that the MMM complex functions like a fishing pole: a long, flexible helix attached to a membrane platform suspends an activated and precisely oriented RING domain—like a fishhook—to ubiquitylate the cytoplasmic surfaces of target receptors. Our structure explains how mutations in MEGF8 cause multi-organ birth defects in humans and defines a paradigm for receptor regulation by ubiquitylation.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?